Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Ventricular Fibrillation

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Ventricular Fibrillation in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schneider, A1
Teschendorf, P1
Vogel, P1
Russ, N1
Knapp, J1
Böttiger, BW1
Popp, E1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Ventricular Fibrillation

ArticleYear
Facilitation of hypothermia by quinpirole and 8-OH-DPAT in a rat model of cardiac arrest.
    Resuscitation, 2012, Volume: 83, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Body Temperature; Cardiopulmonary Resuscitation; Di

2012